Clinically proven
and backed by science
FDA-authorized
and physician prescribed
Available through VA
for Veterans
Drug free solution
and noninvasive

AS SEEN ON MILITARY MAKEOVER

Modius Sleep is available to Veterans through the VA

Noninvasive medical devices to treat some of the world's greatest health concerns.

FDA-cleared. Exclusively available to Veterans through the VA.
Girl wearing Modius Sleep headset and looking off-screen
Your Health. Our Technology
Our mission is to Make Life Better. We understand that living with chronic health conditions can greatly impact your daily life. Many medications and treatments come with side effects that can prevent you from reaching your full potential and living the life you want.
 
Modius technology puts your health and wellbeing first, helping you live your best life.
Designed by Neurologists. Supported by science.

Latest News

FDA Grants World's First Neuromodulation Device to Treat Symptoms of PTSD

The U.S. Food and Drug Administration has granted medical device approval to a breakthrough treatment that could transform the lives of veterans suffering from Post-Traumatic Stress Disorder (PTSD). The official FDA De Novo approval for Modius Spero makes it the world's first neuromodulation device to receive authorization by the FDA to treat symptoms associated with PTSD, a condition that affects an estimated 13 million Americans a year.

Neurovalens granted EU and UK approval for innovative insomnia device

Neurovalens, a global leader in non-invasive neuro-technology, has had its first product approved for sale in Europe and the UK after achieving EU Medical Device Regulation (MDR) compliance for Modius Sleep, it’s prescribed treatment for insomnia. It is among the first Northern Ireland-based companies to achieve EU MDR certification, placing it alongside some of the world's leading medical device manufacturers.

Neurovalens at WHX Dubai 9–12 February 2026.

Neurovalens is delighted to be joining the Association of British HealthTech Industries (ABHI) at WHX Dubai 2026, the Middle East’s flagship healthcare and life sciences event, taking place from 9–12 February 2026 at Expo City Dubai.

Neurovalens secures £6m investment in funding round led by Investment Fund for Northern Ireland

Neurovalens, a global leader in non-invasive neuro-technology, has announced the successful closure of a £6m investment round, led by the Investment Fund for Northern Ireland (IFNI).